IgA anti-tissue transglutaminase antibodies, first line in the diagnosis of celiac disease

Clinical Laboratory

Volumn 57, Issue 9-10, 2011, Pages 695-701

  Samaşca, Gabriel ^a   Iancu, Mihaela ^a   Farcǎu, Dorin ^a   Butnariu, Angela ^a   Pop, Tudor ^a   Pîrvan, Alexandru ^a   Andreica, Mariana ^a   Miu, Nicolae ^a   Cristea, Victor ^a   Dejica, Doru ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Associated diseases; Celiac disease; IgA anti tissue transglutaminase antibodies

Indexed keywords

ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A TISSUE TRANSGLUTAMINASE ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELIAC DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; PREDICTIVE VALUE; PROTEIN CALORIE MALNUTRITION; SENSITIVITY AND SPECIFICITY;

AREA UNDER CURVE; AUTOANTIBODIES; CELIAC DISEASE; CHILD; CHILD NUTRITION DISORDERS; COMORBIDITY; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALABSORPTION SYNDROMES; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROTEIN-ENERGY MALNUTRITION; ROC CURVE; ROMANIA; TRANSGLUTAMINASES;

EID: 80054786359     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. NIH Consensus Development Conference on Celiac Disease. NIH Consens State Sci Statements 2004;21:1-23.
2. James SP. This month at the NIH: Final statement of NIH Consensus Conference on Celiac disease. Gastroenterology 2005;128-36.
3. Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006;101:2333-40. (Pubitemid 44477562)
4. Roth EB, Stenberg P, Book C, et al. Antibodies against transglutaminases, peptidylarginine deiminase, and citrulline in rheumatoid arthritis; new pathways to epitope spreading. Clin. Exp. Rheumatol 2006;24:12-8.
5. Fasano A, Araya M, Bhatnagar S, et al. Consensus guidelines. J Pediatr Gastroenterol Nutr 2008;47:214-9.
6. AGA - Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006;131:1977-80.
7. Silvester JA, Rashid M. Long-term follow-up of individuals with celiac disease: an evaluation of current practice guidelines. Can J Gastroenterol 2007;21:557-64. (Pubitemid 350011438)
8. Kaukinen K, Collin P, Mäki M. Celiac disease - a diagnostic and therapeutic challenge. Duodecim 2010;126:245-54.
9. Kurppa K, Ashorn M, Iltanen S, et al. Celiac Disease without Villous Atrophy in Children: A Prospective Study. J Pediatr 2010 Apr 16. [In press]
10. Hogen Esch CE, Csizmadia GD, van Hoogstraten IM, Schreurs MW, Mearin ML, von Blomberg BM. Childhood coeliac disease: towards an improved serological mass screening strategy. Aliment Pharmacol Ther 2010;31:760-6.
11. West J, Lloyd CA, Hill PG, et al. IgA-antitissue transglutaminase: validation of a commercial assay for diagnosing coeliac disease. Clin Lab 2002;48:241-6. (Pubitemid 34619157)
12. Johnston SD, McMillan SA, Collins JS, et al. A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease. Eur J Gastroenterol Hepatol 2003;15:1001-4. (Pubitemid 37094300)
13. Viola L, Lugli L, Melegari A, et al. Antitransglutaminase enzyme-linked immune-adsorbed assay in coeliac disease diagnosis: evaluation of a diagnostic algorithm. Pediatr Med Chir 2004;26:126-31.
14. Samaşca G, Pîrvan A, Farcǎ;u D, Dejica D. Tissue transglutaminase antibodies. Medical Practice 2010;2:88-91.
15. Mustalahti K, Catassi C, Reunanen A, et al. - members of the Coeliac EU Cluster, Epidemiology. The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project. Ann Med 2010;42:587-95.
16. Vivas S, Ruiz de Morales JG, Riestra S, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 2009;15:4775-80.
17. Godfrey JD, Brantner TL, Brinjikji W, et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010;139:763-9.
18. Biagi F, Klersy C, Balduzzi D, Corazza GR. Are we not overestimating the prevalence of coeliac disease in the general population? Ann Med 2010;42:557-61.
19. Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008;27:572-7. (Pubitemid 351316782)
20. Mothes T, Uhlig HH, Richter T. Recent aspects of antibody determination for the diagnosis of coeliac disease. Dtsch Med Wochenschr 2009;134:1525-8.
21. Abrantes-Lemos CP, Nakhle MC, Damiao AO, et al. Performance of two commercial ELISAs for detecting IgA anti-human and anti-guinea pig tissue transglutaminase antibodies. Clin Lab 2010;56:29-35.
22. Sugai E, Moreno ML, Hwang HJ, et al. Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable? World J Gastroenterol 2010;16:3144-52.